Pfizer Ventures and Chiesi Ventures-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

Aier Eye Hospital was among the participants in a series B-plus round that took the cancer treatment and test developer's overall funding to more than $65m.

Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

WuXi AppTec’s Corporate Venture Fund was among the participants in a series A round disclosed as the precision medicine startup emerged from stealth.

The medical social network operator will target chronic disease management startups through the $76.3m fund, formed with Wuhan S&T Investment and China Merchants Bank.

Omron and Qualcomm Ventures returned to help AliveCor close a series E round that will fund the bolstering of its advanced ECG system.

The $11.5m Echo Health Ventures-backed round more than doubled the healthcare navigation app developer's overall funding.

MTG Ventures and Ohara Pharmaceutical backed the second close of the medical data modelling technology developer’s latest round, which stands at $12.4m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.